Can CoQ10 improve egg quality or live birth after IVF? Human trials have reported encouraging egg and embryo measures, but these are different from having a baby. The selected studies below explain why CoQ10 and mitochondrial research attract interest, and why results in aging mice cannot establish a benefit for women undergoing fertility treatment.
CoQ10 and egg energy: biological promise, clinical uncertainty
CoQ10 (coenzyme Q10) is discussed as a supplement before in vitro fertilization (IVF). The question for women preparing for fertility treatment is whether it improves outcomes that matter to them, rather than simply whether it has a biological role in the egg.
To start with the conclusion, CoQ10 is a naturally occurring substance involved in mitochondrial energy metabolism within the egg. However, this does not mean that “taking it guarantees pregnancy.” The reason reproductive medicine researchers are interested in it is related to the decline in mitochondrial function observed in aging eggs.
CoQ10, mitochondria and egg energy
Mitochondria are energy-producing organelles found in most human cells. The egg is no exception. In fact, the egg is one of the cells with the highest number of mitochondria in the human body. This is because an enormous amount of energy is required for the processes of fertilization and embryonic cleavage.
Mitochondrial changes are one area of research into reproductive aging. Experimental work links impaired energy production with abnormal chromosome-separating structures in eggs. This is a possible mechanism, not a complete explanation of age-related infertility or proof that a supplement prevents chromosome errors in women.
This is where CoQ10 enters the picture.
The Power to Create an Embryo Depends on the Power Plant Inside the Egg
CoQ10 is a substance directly involved in the energy production process within the mitochondria. In simple terms, it acts as an assistant that helps the cellular power plant produce electricity. It also has antioxidant functions.
What animal and human IVF studies found
In a 2015 Aging Cell study, Ben-Meir and colleagues found improved egg mitochondrial function and reproductive outcomes after CoQ10 supplementation in aging mice. The study also examined CoQ-related enzyme expression in human eggs, but it was not a trial showing that women who take CoQ10 have more live births.
A 2018 randomized trial at Peking University Third Hospital enrolled 186 women younger than 35 with diminished ovarian reserve; 169 were analyzed. After 60 days of CoQ10 or no pretreatment, the CoQ10 group had more retrieved eggs and more high-quality day-3 embryos. AMH and antral follicle count did not improve. Clinical pregnancy and live birth differences were not statistically significant. The trial was open-label, excluded 17 women from the treatment arm, and was designed around an embryo outcome rather than live birth. Its results cannot simply be extended to older women.
Do better embryo measures mean more live births?
Better egg or embryo measures do not automatically establish a live birth benefit. In a separate 2014 double-blind, placebo-controlled trial in women aged 35–43, 39 were randomized and 24 completed the IVF–ICSI cycle. No statistically significant outcome differences were detected. It stopped early because of concerns about the polar body biopsy procedure and was underpowered; the stopping decision was not evidence that CoQ10 caused harm. These selected trials leave clinical benefit uncertain rather than proving either benefit or no effect.
Safety and the limits of supplement claims
CoQ10 is not established by these studies as a way to reverse egg aging or guarantee pregnancy. Safety also needs its own assessment. The US National Center for Complementary and Integrative Health notes possible mild digestive upset or insomnia and interactions with warfarin, insulin and some cancer treatments. A favorable biological rationale is not enough to recommend routine use; patients should discuss supplements and other medicines with their clinician.
The possibility of supporting energy production in remaining eggs is a research question, especially where ovarian response is limited. It should not be read as proof that CoQ10 creates new eggs or restores ovarian reserve. Egg quantity and developmental competence both matter; the studies discussed here do not establish that one should replace the other as a treatment goal.
Researchers study CoQ10 because it participates in mitochondrial energy metabolism. That biochemical role does not establish selective protection of mitochondria over the nucleus, or demonstrate a clinical fertility benefit on its own.
Mitochondrial function offers a useful research perspective alongside hormonal and other aspects of fertility care. Further trials need to establish whether changes in laboratory measures translate into more live births.
Editorial note: An anonymous specialist quotation in an earlier version could not be verified and has been withdrawn.
The interest in CoQ10 highlights questions about cellular energy as well as egg number and development. It does not establish that fertility treatment has entered an “era of energy,” or that mitochondrial supplements can replace established care. The clinically useful question remains whether a particular intervention improves outcomes for a defined group of patients.
Research references and scope
This article discusses selected studies, not a comprehensive review or a prescription for CoQ10 dosing.
Xu et al. (2018), Reproductive Biology and Endocrinology: randomized IVF–ICSI trial in young women with reduced ovarian reserve. DOI: 10.1186/s12958-018-0343-0.
Bentov et al. (2014), Clinical Medicine Insights: Reproductive Health: randomized placebo-controlled IVF–ICSI trial in women aged 35–43. DOI: 10.4137/CMRH.S14681.
Ben-Meir et al. (2015), Aging Cell: mechanistic and reproductive-aging mouse research, with human egg expression measurements. DOI: 10.1111/acel.12368.
US National Center for Complementary and Integrative Health: Coenzyme Q10 information and safety considerations.
For another decision facing patients with a limited number of eggs, see freeze-all versus fresh transfer in low-prognosis IVF. That trial concerns transfer strategy, not CoQ10 supplementation.